Multi-organ proteomic landscape of COVID-19 autopsies

Cell. 2021 Feb 4;184(3):775-791.e14. doi: 10.1016/j.cell.2021.01.004. Epub 2021 Jan 9.

Abstract

The molecular pathology of multi-organ injuries in COVID-19 patients remains unclear, preventing effective therapeutics development. Here, we report a proteomic analysis of 144 autopsy samples from seven organs in 19 COVID-19 patients. We quantified 11,394 proteins in these samples, in which 5,336 were perturbed in the COVID-19 patients compared to controls. Our data showed that cathepsin L1, rather than ACE2, was significantly upregulated in the lung from the COVID-19 patients. Systemic hyperinflammation and dysregulation of glucose and fatty acid metabolism were detected in multiple organs. We also observed dysregulation of key factors involved in hypoxia, angiogenesis, blood coagulation, and fibrosis in multiple organs from the COVID-19 patients. Evidence for testicular injuries includes reduced Leydig cells, suppressed cholesterol biosynthesis, and sperm mobility. In summary, this study depicts a multi-organ proteomic landscape of COVID-19 autopsies that furthers our understanding of the biological basis of COVID-19 pathology.

Keywords: COVID-19; angiogenesis; autopsy; cathepsin; coagulation; fibrosis; hyperinflammation; pathology; proteome; tissue.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autopsy
  • COVID-19 / metabolism*
  • COVID-19 / pathology
  • COVID-19 / therapy
  • Female
  • Gene Expression Regulation*
  • Humans
  • Male
  • Organ Specificity
  • Proteome / biosynthesis*
  • Proteomics*
  • SARS-CoV-2 / metabolism*

Substances

  • Proteome